Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-22 · accession 0001209191-23-059683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-26 | 2023-12-22 | ELTX | GKCC, LLC | 10% | P - Purchase | $5.81 | +1.21M | 1.92M | +173% | +$7.05M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-22 | P | A | 1,213,000 | $5.81 | 1,915,639 | I Held by GKCC, LLC | — | — | (F1) Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. |